PAHO/WHO meeting to review the regulation of vaccines and drugs for responding to Pandemic Influenza H1N1
As part of the activities to strengthen the national drug regulatory authorities (NRA), the Pan American Health Organization (PAHO), in conjunction with the World Health Organization (WHO), held this meeting in Buenos Aires, Argentina, from 1 to 3 December 2009. The main objective was to review regulatory aspects of the introduction of pandemic influenza A (H1N1) vaccines in the participating countries, in terms of: licensing, laboratory tests, and the monitoring of adverse events (in coordination with the Expanded Program on Immunization or the responsible officials of the respective Ministries of Health).
The meeting was attended by representatives of the NRA of Argentina, Brazil, Canada, Chile, Colombia, Cuba, the United States, Peru, Paraguay, and Uruguay.
All the information on this event can be found below:
- WHO Guideline on Regulatory Preparedness for Human Pandemic Influenza Vaccines, October 2007.
- Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines. May 2009
- WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update. July 2009.
Conclusions of the meeting (Spanish)